Recently, ProCT has been shown to be highly accurate in excluding MTC in patients with indeterminate calcitonin values (i.e., 10–100 pg/mL), making a two-step procedure actionable. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.